🇺🇸 FDA
Patent

US 6103711

Inhibitors of interleukin-1.beta. converting enzyme

expired A61KA61K38/00A61P

Quick answer

US patent 6103711 (Inhibitors of interleukin-1.beta. converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61P, A61P25/00, A61P25/28